Edward Tenthoff
Stock Analyst at Piper Sandler
(2.27)
# 2,645
Out of 4,761 analysts
191
Total ratings
38.98%
Success rate
-0.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Edward Tenthoff
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MESO Mesoblast | Reiterates: Overweight | $15 → $24 | $16.37 | +46.61% | 5 | Feb 7, 2025 | |
| LEGN Legend Biotech | Reiterates: Overweight | $78 | $39.70 | +96.47% | 4 | Dec 30, 2024 | |
| IPSC Century Therapeutics | Maintains: Overweight | $12 → $4 | $0.73 | +447.87% | 7 | Dec 30, 2024 | |
| XNCR Xencor | Upgrades: Overweight | $20 → $30 | $15.74 | +90.60% | 4 | Dec 2, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Overweight | $62 → $45 | $19.90 | +126.13% | 11 | Nov 27, 2024 | |
| ALNY Alnylam Pharmaceuticals | Reiterates: Overweight | $296 | $250.59 | +18.12% | 13 | Nov 18, 2024 | |
| MRNA Moderna | Reiterates: Overweight | $115 → $69 | $35.53 | +94.20% | 12 | Nov 18, 2024 | |
| OMGA Omega Therapeutics | Maintains: Overweight | $9 → $4 | $0.16 | +2,401.56% | 5 | Nov 15, 2024 | |
| KRON Kronos Bio | Downgrades: Neutral | $6 → $1 | $1.00 | - | 7 | Nov 14, 2024 | |
| TPST Tempest Therapeutics | Maintains: Overweight | $8 → $5 | $0.86 | +481.13% | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $4.81 | +274.22% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $35 | $15.00 | +133.33% | 1 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $11 | $1.77 | +521.47% | 6 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $53 | $14.01 | +278.30% | 5 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $20 | $2.98 | +571.14% | 3 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $3 | $1.68 | +78.57% | 6 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $13 → $5 | $0.17 | +2,768.62% | 6 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $3 | $1.32 | +127.27% | 4 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $16 | $6.22 | +157.23% | 3 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $105 | $47.91 | +119.16% | 6 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $4 → $6 | $1.42 | +322.54% | 7 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $5 | $0.16 | +2,984.52% | 4 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $2.04 | +145.10% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $15 | $3.85 | +289.61% | 3 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $39 → $56 | $36.81 | +52.13% | 4 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $55 | $17.77 | +209.51% | 6 | Oct 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $31 | $1.25 | +2,380.00% | 5 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $3 | $0.47 | +542.26% | 1 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $6 | $0.72 | +729.99% | 4 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $9 | $0.80 | +1,020.10% | 3 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $37 → $44 | $18.47 | +138.22% | 1 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $76 → $37 | $11.66 | +217.32% | 2 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $112,332 → $32,560 | $3.47 | +938,228.53% | 3 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $250 → $354 | $644.48 | -45.07% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $105 → $135 | $1.36 | +9,826.47% | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $261 → $323 | $484.24 | -33.30% | 6 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $33 → $36 | $36.85 | -2.31% | 2 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $50 → $25 | $1.57 | +1,492.36% | 2 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $150 | $0.64 | +23,337.50% | 1 | Jan 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $53 | $1.38 | +3,740.58% | 2 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $1,380 | $1.09 | +126,505.50% | 1 | Dec 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $700.33 | - | 11 | Feb 13, 2017 |
Mesoblast
Feb 7, 2025
Reiterates: Overweight
Price Target: $15 → $24
Current: $16.37
Upside: +46.61%
Legend Biotech
Dec 30, 2024
Reiterates: Overweight
Price Target: $78
Current: $39.70
Upside: +96.47%
Century Therapeutics
Dec 30, 2024
Maintains: Overweight
Price Target: $12 → $4
Current: $0.73
Upside: +447.87%
Xencor
Dec 2, 2024
Upgrades: Overweight
Price Target: $20 → $30
Current: $15.74
Upside: +90.60%
Arrowhead Pharmaceuticals
Nov 27, 2024
Maintains: Overweight
Price Target: $62 → $45
Current: $19.90
Upside: +126.13%
Alnylam Pharmaceuticals
Nov 18, 2024
Reiterates: Overweight
Price Target: $296
Current: $250.59
Upside: +18.12%
Moderna
Nov 18, 2024
Reiterates: Overweight
Price Target: $115 → $69
Current: $35.53
Upside: +94.20%
Omega Therapeutics
Nov 15, 2024
Maintains: Overweight
Price Target: $9 → $4
Current: $0.16
Upside: +2,401.56%
Kronos Bio
Nov 14, 2024
Downgrades: Neutral
Price Target: $6 → $1
Current: $1.00
Upside: -
Tempest Therapeutics
Nov 13, 2024
Maintains: Overweight
Price Target: $8 → $5
Current: $0.86
Upside: +481.13%
Nov 5, 2024
Initiates: Overweight
Price Target: $18
Current: $4.81
Upside: +274.22%
Oct 21, 2024
Initiates: Overweight
Price Target: $35
Current: $15.00
Upside: +133.33%
Oct 11, 2024
Reiterates: Overweight
Price Target: $11
Current: $1.77
Upside: +521.47%
Sep 23, 2024
Reiterates: Overweight
Price Target: $53
Current: $14.01
Upside: +278.30%
Sep 20, 2024
Reiterates: Overweight
Price Target: $20
Current: $2.98
Upside: +571.14%
Sep 17, 2024
Reiterates: Overweight
Price Target: $3
Current: $1.68
Upside: +78.57%
Aug 13, 2024
Reiterates: Overweight
Price Target: $13 → $5
Current: $0.17
Upside: +2,768.62%
Jul 26, 2024
Maintains: Overweight
Price Target: $8 → $3
Current: $1.32
Upside: +127.27%
Jun 28, 2024
Reiterates: Overweight
Price Target: $16
Current: $6.22
Upside: +157.23%
Jun 17, 2024
Reiterates: Overweight
Price Target: $105
Current: $47.91
Upside: +119.16%
Jun 17, 2024
Upgrades: Overweight
Price Target: $4 → $6
Current: $1.42
Upside: +322.54%
Apr 3, 2024
Maintains: Overweight
Price Target: $5
Current: $0.16
Upside: +2,984.52%
Mar 5, 2024
Maintains: Overweight
Price Target: $6 → $5
Current: $2.04
Upside: +145.10%
Feb 28, 2024
Maintains: Overweight
Price Target: $13 → $15
Current: $3.85
Upside: +289.61%
Feb 27, 2024
Maintains: Overweight
Price Target: $39 → $56
Current: $36.81
Upside: +52.13%
Oct 23, 2023
Maintains: Overweight
Price Target: $70 → $55
Current: $17.77
Upside: +209.51%
Aug 14, 2023
Maintains: Overweight
Price Target: $28 → $31
Current: $1.25
Upside: +2,380.00%
Dec 12, 2022
Initiates: Overweight
Price Target: $3
Current: $0.47
Upside: +542.26%
Nov 4, 2022
Maintains: Overweight
Price Target: $13 → $6
Current: $0.72
Upside: +729.99%
Sep 7, 2022
Maintains: Overweight
Price Target: $7 → $9
Current: $0.80
Upside: +1,020.10%
Aug 25, 2022
Maintains: Overweight
Price Target: $37 → $44
Current: $18.47
Upside: +138.22%
May 23, 2022
Maintains: Overweight
Price Target: $76 → $37
Current: $11.66
Upside: +217.32%
May 13, 2022
Maintains: Overweight
Price Target: $112,332 → $32,560
Current: $3.47
Upside: +938,228.53%
Nov 29, 2021
Upgrades: Overweight
Price Target: $250 → $354
Current: $644.48
Upside: -45.07%
Sep 20, 2021
Maintains: Overweight
Price Target: $105 → $135
Current: $1.36
Upside: +9,826.47%
Jul 30, 2021
Maintains: Overweight
Price Target: $261 → $323
Current: $484.24
Upside: -33.30%
Feb 16, 2021
Maintains: Overweight
Price Target: $33 → $36
Current: $36.85
Upside: -2.31%
May 12, 2020
Downgrades: Neutral
Price Target: $50 → $25
Current: $1.57
Upside: +1,492.36%
Jan 27, 2020
Initiates: Overweight
Price Target: $150
Current: $0.64
Upside: +23,337.50%
Jan 6, 2020
Maintains: Overweight
Price Target: $26 → $53
Current: $1.38
Upside: +3,740.58%
Dec 11, 2017
Initiates: Overweight
Price Target: $1,380
Current: $1.09
Upside: +126,505.50%
Feb 13, 2017
Upgrades: Overweight
Price Target: n/a
Current: $700.33
Upside: -